riluzole has been researched along with Body Weight in 7 studies
Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.
Body Weight: The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms.
Excerpt | Relevance | Reference |
---|---|---|
"Riluzole is the first disease-modifying therapy for amyotrophic lateral sclerosis (ALS) approved in 1995 by the Food and Drug Administration in the USA, and is now available worldwide." | 8.02 | Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis. ( Howard, D; Naud, S; Tandan, R; Thakor, K; Waheed, W, 2021) |
"Riluzole is the first disease-modifying therapy for amyotrophic lateral sclerosis (ALS) approved in 1995 by the Food and Drug Administration in the USA, and is now available worldwide." | 4.02 | Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis. ( Howard, D; Naud, S; Tandan, R; Thakor, K; Waheed, W, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 4 (57.14) | 29.6817 |
2010's | 2 (28.57) | 24.3611 |
2020's | 1 (14.29) | 2.80 |
Authors | Studies |
---|---|
Thakor, K | 1 |
Naud, S | 1 |
Howard, D | 1 |
Tandan, R | 1 |
Waheed, W | 1 |
Clavelou, P | 1 |
Blanquet, M | 1 |
Peyrol, F | 1 |
Ouchchane, L | 1 |
Gerbaud, L | 1 |
Schmidt, J | 1 |
Schmidt, T | 1 |
Golla, M | 1 |
Lehmann, L | 1 |
Weber, JJ | 1 |
Hübener-Schmid, J | 1 |
Riess, O | 1 |
Del Signore, SJ | 1 |
Amante, DJ | 1 |
Kim, J | 1 |
Stack, EC | 1 |
Goodrich, S | 1 |
Cormier, K | 1 |
Smith, K | 1 |
Cudkowicz, ME | 1 |
Ferrante, RJ | 1 |
Aziz, NA | 1 |
van der Burg, JM | 1 |
Landwehrmeyer, GB | 1 |
Brundin, P | 1 |
Stijnen, T | 1 |
Roos, RA | 1 |
Fumagalli, E | 1 |
Bigini, P | 1 |
Barbera, S | 1 |
De Paola, M | 1 |
Mennini, T | 1 |
Kennel, P | 1 |
Revah, F | 1 |
Bohme, GA | 1 |
Bejuit, R | 1 |
Gallix, P | 1 |
Stutzmann, JM | 1 |
Imperato, A | 1 |
Pratt, J | 1 |
1 trial available for riluzole and Body Weight
Article | Year |
---|---|
Weight loss in Huntington disease increases with higher CAG repeat number.
Topics: Adult; Aged; Animals; Body Mass Index; Body Weight; Disease Models, Animal; Energy Intake; Female; H | 2008 |
6 other studies available for riluzole and Body Weight
Article | Year |
---|---|
Effect of riluzole on weight in short-term and long-term survivors of amyotrophic lateral sclerosis.
Topics: Amyotrophic Lateral Sclerosis; Body Weight; Humans; Neuroprotective Agents; Prospective Studies; Ril | 2021 |
Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Topics: Aged; Amyotrophic Lateral Sclerosis; Body Mass Index; Body Weight; Cohort Studies; Disease Progressi | 2013 |
In vivo assessment of riluzole as a potential therapeutic drug for spinocerebellar ataxia type 3.
Topics: Animals; Ataxin-3; Body Weight; Brain; Calbindins; Disease Models, Animal; Fluorescence Resonance En | 2016 |
Combined riluzole and sodium phenylbutyrate therapy in transgenic amyotrophic lateral sclerosis mice.
Topics: Acetylation; Amyotrophic Lateral Sclerosis; Animals; Anterior Horn Cells; Body Weight; Drug Synergis | 2009 |
Riluzole, unlike the AMPA antagonist RPR119990, reduces motor impairment and partially prevents motoneuron death in the wobbler mouse, a model of neurodegenerative disease.
Topics: Animals; Body Weight; Brain-Derived Neurotrophic Factor; CD11b Antigen; Cell Death; Choline O-Acetyl | 2006 |
Riluzole prolongs survival and delays muscle strength deterioration in mice with progressive motor neuronopathy (pmn).
Topics: Animals; Body Weight; Disease Models, Animal; Hand Strength; Mice; Mice, Transgenic; Motor Neuron Di | 2000 |